Bing Xu

Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties

Nga Chi Yip, Ivo S. Fombon, P Liu et al. · British Journal of Cancer · 2011 · 410 citations · Full text

Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Ziju Y. Xu-Monette, Min Xiao, Qingyan Au et al. · Cancer Immunology Research · 2019 · 175 citations

Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2

Bing Xu, Shiyun Wang, Rongwei Li et al. · Cell Death and Disease · 2017 · 140 citations · Full text

HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia

Huacheng Luo, Ganqian Zhu, Melanie A. Eshelman et al. · Molecular Cell · 2022 · 140 citations · Full text

Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines

Xiaoxia Guo, Bing Xu, Shuchita Pandey et al. · Cancer Letters · 2009 · 129 citations

Medicine, Pharmacology, Cytotoxic Effect +9